Chandan Healthcare IPO Overview
Chandan Healthcare IPO is a book built issue of Rs 107.36 crores. The issue is a combination of fresh issue of 44.52 lakh shares aggregating to Rs 70.79 crores and offer for sale of 23.00 lakh shares aggregating to Rs 36.57 crores.
Chandan Healthcare IPO opens for subscription on February 10, 2025 and closes on February 12, 2025. The allotment for the Chandan Healthcare IPO is expected to be finalized on Thursday, February 13, 2025. Chandan Healthcare IPO will list on NSE SME with tentative listing date fixed as Monday, February 17, 2025.
Chandan Healthcare IPO price band is set at ₹151 to ₹159 per share. The minimum lot size for an application is 800. The minimum amount of investment required by retail investors is ₹1,27,200. The minimum lot size investment for HNI is 2 lots (1,600 shares) amounting to ₹2,54,400.
Unistone Capital Pvt Ltd is the book running lead manager of the Chandan Healthcare IPO, while Kfin Technologies Limited is the registrar for the issue. The market maker for Chandan Healthcare IPO is R.K.Stock Holding Private Limited.
Refer to Chandan Healthcare IPO RHP for detailed information.
Chandan Healthcare IPO Important dates
Chandan Healthcare IPO opens on February 10, 2025, and closes on February 12, 2025.
IPO Open Date | Monday, February 10, 2025 |
IPO Close Date | Wednesday, February 12, 2025 |
Basis of Allotment | Thursday, February 13, 2025 |
Initiation of Refunds | Friday, February 14, 2025 |
Credit of Shares to Demat | Friday, February 14, 2025 |
Listing Date | Monday, February 17, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on February 12, 2025 |
Chandan Healthcare IPO Financial Performance
Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | ||||||||||||||||||||||||||||||||||||
Assets | 170.06 | 128.86 | 97.83 | 81.23 | ||||||||||||||||||||||||||||||||||||
Revenue | 167.99 | 177.96 | 137.03 | 119.92 | ||||||||||||||||||||||||||||||||||||
Profit After Tax | 17.42 | 16.36 | 3.59 | -1.09 | ||||||||||||||||||||||||||||||||||||
Net Worth | 41.09 | 27.3 | 23.93 | |||||||||||||||||||||||||||||||||||||
Reserves and Surplus | 34.31 | 21.16 | 7.37 | 4 | ||||||||||||||||||||||||||||||||||||
Total Borrowing | 51.92 | 42.01 | 21.36 | 16.58 | ||||||||||||||||||||||||||||||||||||
Amount in ₹ Crore |
Chandan Healthcare IPO Key Performance Indicator
The market capitalization of Chandan Healthcare IPO is Rs 388.79 Cr.
KPI as of Sun, Mar 31, 2024.
KPI | Values |
---|---|
ROE | 47.50% |
ROCE | 35.20% |
Debt/Equity | 1.02 |
RoNW | 39.54% |
PAT Margin | 9.26 |
Price to Book Value | 7.73 |
Pre IPO | Post IPO | |
---|---|---|
EPS (Rs) | 8.18 | 9.50 |
P/E (x) | 19.44 | 16.74 |
- The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2024 that is available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of December 31, 2024 that is available in RHP.
Chandan Healthcare IPO Objectives
The company proposes to utilize the Net Proceeds from the Offer towards the following objects:
- Setting up a new Flagship Diagnostic Centre in Jankipuram, Lucknow, Uttar Pradesh.
- Setting up a new Central Reference laboratory at Ayodhya, Uttar Pradesh
- Setting up a new Central Reference laboratory at Ashiyana, Lucknow, Uttar Pradesh.
- General corporate purposes.
Chandan Healthcare IPO Lot Size
Investors can bid for a minimum of 800 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 800 | ₹1,27,200 |
Retail (Max) | 1 | 800 | ₹1,27,200 |
HNI (Min) | 2 | 1,600 | ₹2,54,400 |
Lot Size Calculator |
Chandan Healthcare IPO Details
IPO Date | February 10, 2025 to February 12, 2025 |
Listing Date | [.] |
Face Value | ₹10 per share |
Price Band | ₹151 to ₹159 per share |
Lot Size | 800 Shares |
Total Issue Size | 67,52,000 shares (aggregating up to ₹107.36 Cr) |
Fresh Issue | 44,52,064 shares (aggregating up to ₹ 70.79 Cr) |
Offer for Sale | 22,99,936 shares of ₹10 (aggregating up to ₹36.57 Cr) |
Issue Type | Book Built Issue IPO |
Listing At | NSE SME |
Share Holding Pre Issue | 2,00,00,000 shares |
Share Holding Post Issue | 2,44,52,064 shares |
Market Maker Portion | 3,39,200 shares R.K.Stock Holding Private Limited |
Chandan Healthcare IPO Company Overview and Services
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centres in North India with pathology and radiology testing services.
As of December 31, 2024, the company operates one flagship laboratory, seven central laboratories, and twenty-six satellite centres, with over three hundred collection centres in more than 23 cities across Uttar Pradesh and over 19 in Uttarakhand.
As of December 31, 2024, the company offers 1,496 tests across different specialities. The test menu includes
- 481 routine pathology tests in basic biochemistry and haematology, plus 1,015 specialised tests like immunohistopathology and molecular pathology, and
- 545 radiology tests, including x-rays, ultrasonography, CT, MRI, and specialised CT scans.
The radiology facilities have eleven CT scanners and four MRI machines.
As of December 31, 2024, the company employed 15 radiologists, 23 pathologists, and over 161 other qualified professionals.
Products and services:
The company primarily provides diagnostic services and ad hoc sales of consumables like X-ray films and reagents. Its subsidiary, Chandan Pharmacy Limited, operates medical stores offering a range of pharmaceutical products.
- Routine Pathology Tests
- Specialized Pathology Tests
- Radiology Tests
- Preventive and Wellness Services
- Home Collection Service
Competitive Strength:
- Strong geographic presence in Uttarakhand, including 39 tier-two cities and towns.
- Integrated diagnostics provider offering pathology, radiology testing, and medical consultations.
- Track record of profitability and consistent financial performance.
- Dedicated management team with significant industry experience.
Chandan Healthcare IPO SWOT Analysis
Strengths:
- Strong Regional Presence: Chandan Healthcare has a significant presence in Uttarakhand and Uttar Pradesh, particularly in tier-two cities and towns. This regional focus can provide a competitive advantage and brand recognition.
- Integrated Services: The company offers a wide range of diagnostic services, including pathology, radiology, and medical consultations. This integrated approach can attract more customers and provide a comprehensive healthcare solution.
- Established Track Record: Chandan Healthcare has a history of profitability and consistent financial performance. This can instill confidence in investors and demonstrate the company’s operational efficiency.
- Experienced Management: The company has a dedicated management team with significant experience in the healthcare industry. This expertise can be crucial for navigating the challenges and opportunities in the sector.
Weaknesses:
- Dependence on Regional Market: While a strong regional presence is a strength, it also creates a dependence on the specific market conditions and healthcare dynamics of Uttarakhand and Uttar Pradesh. Any adverse changes in these regions could impact the company’s performance.
- Competition: The diagnostic services market is competitive, with both organized and unorganized players. Chandan Healthcare faces competition from established diagnostic chains, hospitals, and smaller independent labs.
- Working Capital Intensive: The company’s operations are working capital intensive, which can strain cash flow. Managing receivables and inventory efficiently is crucial for maintaining financial health.
- Limited Service Diversification: While Chandan Healthcare offers a range of diagnostic services, it may have limited diversification in terms of specialized healthcare offerings or expansion into other related areas.
Opportunities:
- Growing Healthcare Market: The healthcare industry in India is expanding rapidly, driven by increasing awareness, rising disposable incomes, and an aging population. This presents a significant growth opportunity for diagnostic service providers.
- Technological Advancements: Advancements in diagnostic technologies, such as molecular diagnostics and advanced imaging, can enable Chandan Healthcare to offer more sophisticated and accurate services.
- Expansion into New Areas: The company can explore expanding its operations into new geographical markets, both within its existing regions and beyond. It can also consider diversifying its service offerings to include specialized diagnostics or related healthcare services.
- Strategic Partnerships: Collaborating with hospitals, clinics, and healthcare providers can help Chandan Healthcare expand its reach and customer base.
Threats:
- Regulatory Changes: The healthcare industry is subject to evolving regulations and compliance requirements. Changes in government policies or healthcare standards can impact the company’s operations and costs.
- Economic Downturn: An economic downturn can affect healthcare spending, as individuals and families may prioritize essential expenses. This can impact the demand for diagnostic services.
- Talent Acquisition and Retention: Attracting and retaining qualified healthcare professionals, such as radiologists and pathologists, can be a challenge in a competitive market.
- Data Security and Privacy: With increasing digitalization in healthcare, ensuring the security and privacy of patient data is crucial. Any data breaches or security lapses can damage the company’s reputation and lead to legal issues.
Chandan Healthcare IPO GMP Details
Chandan Healthcare SME IPO last GMP is ₹0, last updated Feb 5th 2025 01:53 PM. With the price band of 159.00, Chandan Healthcare SME IPO’s estimated listing price is ₹159 (cap price + today’s GMP).The expected percentage gain/loss per share is 0.00%.
We update GMP on a daily basis and based on last 3 sessions grey market activities, today IPO GMP trend, no major movement is observed in GMP, expect same trend till listing day. Stay with us to know the daily price trend of Chandan Healthcare SME IPO GMP with expected listing price.
GMP Date | IPO Price | GMP | Sub2 Sauda Rate | Estimated Listing Price | Last Updated |
---|---|---|---|---|---|
05-02-2025 | 159.00 | ₹0 ![]() |
— | ₹159 (0.00%) | 5-Feb-2025 13:53 |
04-02-2025 | ₹0 ![]() |
— | ₹ (0.00%) | 4-Feb-2025 5:55 | |
03-02-2025 | ₹0 ![]() |
— | ₹ (0.00%) | 3-Feb-2025 13:07 |
What is IPO GMP?
The grey market premium (GMP) reflects the unofficial trading price of an IPO before its listing, offering insights into its potential market performance. A positive GMP indicates that the IPO may yield profits, while a negative GMP suggests a possible discount upon listing. However, it’s essential to recognize that IPO GMP can be highly volatile. Therefore, investors should not make decisions solely based on the GMP but should thoroughly assess all relevant factors before investing.
Chandan Healthcare IPO Subscription Status
Note that the bidding starts at 10 AM and ends at 5 PM on the days when the public issue is open.
Chandan Healthcare IPO Allotment status
Chandan Healthcare IPO allotment is expected on Thursday, February 13, 2025.
Chandan Healthcare IPO allotment status is not available at this time. Chandan Healthcare IPO – The allotment status will be available once the basis of allotment is finalized. Please revisit us to check the latest updates for Chandan Healthcare Limited IPO allotment status.
Chandan Healthcare IPO Contact Details
Chandan Healthcare Limited
Biotech Park, Sector G,
Jankipuram, Kursi Road,
Lucknow-226021
Phone: +91 8429024430
Email: secretarial@chandan.co.in
Website: https://www.chandandiagnostic.com/
Disclaimer: Investing in Initial Public Offerings (IPOs) involves substantial risk, and financial returns are not guaranteed. The information provided should not be construed as financial or investment advice. Prospective investors are advised to consider their financial situation, investment objectives, and risk tolerance before participating in an IPO. It is recommended to consult with a qualified financial advisor or professional before making any investment decisions. Past performance is not indicative of future results. Investments in IPOs may be subject to market risk, including the potential loss of principal.
Want to Raise money for your company through SME IPO? Read More